Regulus Therapeutics Inc. (NASDAQ:RGLS) Receives Consensus Recommendation of “Moderate Buy” from Analysts
Shares of Regulus Therapeutics Inc. (NASDAQ:RGLS – Get Free Report) have been given a consensus rating of “Moderate Buy” by the six ratings firms that are presently covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average […]
Shares of Regulus Therapeutics Inc. (NASDAQ:RGLS – Get Free Report) have been given a consensus rating of “Moderate Buy” by the six ratings firms that are presently covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average […]
